Ricardo M. Attar

4.9k citations

72 papers · 3.2k indexed · h-index 30

Molecular Biology top 5%
Oncology top 5%
Endocrinology, Diabetes and Metabolism top 1%
Pulmonary and Respiratory Medicine top 5%
Cancer Research top 2%

Co-authors: Marco M. Gottardis Joan M. Carboni Chris H. Takimoto Mark Salvati Roberto Weinmann Michael Gilman Stanley R. Krystek John S. Sack
Topics: Growth Hormone and Insulin-like Growth Factors (17 papers)Monoclonal and Polyclonal Antibodies Research (17 papers)Hormonal and reproductive studies (11 papers)
Cited by: Endocrinology, Diabetes and Metabolism Cancer Research Oncology
Journals: Proceedings of the National Academy of Sciences Nucleic Acids Research Journal of Biological Chemistry
Partner nations: United States Germany Belgium

In The Last Decade

Ricardo M. Attar

72 papers receiving 3.1k citations

Peers

Countries citing papers authored by Ricardo M. Attar

Since Specialization

Citations

This map shows the geographic impact of Ricardo M. Attar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ricardo M. Attar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ricardo M. Attar more than expected).

Fields of papers citing papers by Ricardo M. Attar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ricardo M. Attar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ricardo M. Attar. The network helps show where Ricardo M. Attar may publish in the future.

Co-authorship network of co-authors of Ricardo M. Attar

This figure shows the co-authorship network connecting the top 25 collaborators of Ricardo M. Attar. A scholar is included among the top collaborators of Ricardo M. Attar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ricardo M. Attar. Ricardo M. Attar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ramantamig (JNJ-79635322), a novel T-cell-engaging trispecific antibody targeting BCMA, GPRC5D, and CD3, in multiple myeloma models 2025 ·Blood ·Kodandaram Pillarisetti,Danlin Yang,Leopoldo Luistro,Jianhong Yao,Melissa Smith,(unknown),James Testa,(unknown),Scott R. Brodeur,(unknown),Kathryn Packman,Sanjaya Singh,Ricardo M. Attar,Yusri Elsayed,Ulrike Philippar	3
2	A Novel Bispecific Antibody Targeting EGFR and cMet Is Effective against EGFR Inhibitor–Resistant Lung Tumors 2016 ·Cancer Research ·Sheri L. Moores,Mark L. Chiu,Barbara S. Bushey,Kristen Chevalier,Leopoldo Luistro,(unknown),Randall J. Brezski,Peter Haytko,Thomas J. Kelly,Sheng‐Jiun Wu,Pauline L. Martin,Joost Neijssen,Paul W.H.I. Parren,Janine Schuurman,Ricardo M. Attar,Sylvie Laquerre,Matthew V. Lorenzi,Geoffrey M. Anderson	188
3	Drug safety is a barrier to the discovery and development of new androgen receptor antagonists 2010 ·The Prostate ·William R. Foster,Bruce D. Car,Hong Shi,Paul Lévesque,Mary T. Obermeier,Jinping Gan,Joseph C. Arezzo,(unknown),Joseph Dinchuk,Aaron Balog,Mark Salvati,Ricardo M. Attar,Marco M. Gottardis	92
4	Expression of Insulin Receptor Isoform A and Insulin-like Growth Factor-1 Receptor in Human Acute Myelogenous Leukemia: Effect of the Dual-Receptor Inhibitor BMS-536924 In vitro 2009 ·Cancer Research ·Andrea E. Wahner Hendrickson,Paul Haluska,Paula A. Schneider,David A. Loegering,Kevin Peterson,Ricardo M. Attar,B. Douglas Smith,Charles Erlichman,Marco M. Gottardis,Judith E. Karp,Joan M. Carboni,Scott H. Kaufmann	43
5	Discovery of BMS-641988, a Novel and Potent Inhibitor of Androgen Receptor Signaling for the Treatment of Prostate Cancer 2009 ·Cancer Research ·Ricardo M. Attar,Maria Jure–Kunkel,Aaron Balog,Mary Ellen Cvijic,(unknown),Cheryl A. Rizzo,Liang Schweizer,Thomas Spires,J. Suso Platero,Mary T. Obermeier,Weifang Shan,Mark Salvati,William R. Foster,Joseph Dinchuk,Shen-Jue Chen,Gregory D. Vite,Robert A. Kramer,Marco M. Gottardis	38
6	BMS-754807, a small molecule inhibitor of insulin-like growth factor-1R/IR 2009 ·Molecular Cancer Therapeutics ·Joan M. Carboni,Mark D. Wittman,Zheng Yang,Francis Lee,Ann Greer,Warren Hurlburt,Stephen Hillerman,Carolyn Cao,Glenn H. Cantor,(unknown),Cliff Chen,Lorell Discenza,Krista Menard,Aixin Li,George L. Trainor,Dolatrai M. Vyas,Robert A. Kramer,Ricardo M. Attar,Marco M. Gottardis	218
7	BMS-536924 Reverses IGF-IR-Induced Transformation of Mammary Epithelial Cells and Causes Growth Inhibition and Polarization of MCF7 Cells 2008 ·Clinical Cancer Research ·Beate C. Litzenburger,(unknown),Isere Kuiatse,Joan M. Carboni,Ricardo M. Attar,Marco M. Gottardis,Craig R. Fairchild,Adrian V. Lee	33
8	The Mechanisms of Differential Sensitivity to an Insulin-like Growth Factor-1 Receptor Inhibitor (BMS-536924) and Rationale for Combining with EGFR/HER2 Inhibitors 2008 ·Cancer Research ·Fei Huang,Ann Greer,Warren Hurlburt,Xia Han,(unknown),Gayle Wittenberg,Karen A. Reeves,Jiwen Chen,Douglas Robinson,Aixin Li,Francis Y. Lee,Marco M. Gottardis,Edwin Clark,Lee J. Helman,Ricardo M. Attar,Ashok Dongre,Joan M. Carboni	137
9	Identification of a nonkinase target mediating cytotoxicity of novel kinase inhibitors 2008 ·Molecular Cancer Therapeutics ·Petra Ross‐Macdonald,Heshani de Silva,Qi Guo,Hong Xiao,(unknown),Becky Penhallow,Jay A. Markwalder,Liqi He,Ricardo M. Attar,Tai-An Lin,Steven P. Seitz,Charles Tilford,Judith Wardwell-Swanson,Donald Jackson	102
10	2-(1H-Imidazol-4-yl)ethanamine and 2-(1H-pyrazol-1-yl)ethanamine side chain variants of the IGF-1R inhibitor BMS-536924 2008 ·Bioorganic & Medicinal Chemistry Letters ·Mark G. Saulnier,David B. Frennesson,Mark D. Wittman,Kurt Zimmermann,Upender Velaparthi,David R. Langley,(unknown),(unknown),Joan M. Carboni,Aixin Li,Ann Greer,Zheng Yang,Praveen Balimane,Marco M. Gottardis,Ricardo M. Attar,Dolatrai M. Vyas	20
11	Identification and optimization of a novel series of [2.2.1]-oxabicyclo imide-based androgen receptor antagonists 2008 ·Bioorganic & Medicinal Chemistry Letters ·Mark Salvati,Aaron Balog,Weifang Shan,(unknown),(unknown),(unknown),(unknown),Gregory D. Vite,Ricardo M. Attar,Maria Jure–Kunkel,Jieping Geng,Cheryl A. Rizzo,Marco M. Gottardis,Stanley R. Krystek,Jack Z. Gougoutas,Michael A. Galella,Mary T. Obermeier,Aberra Fura,Gamini Chandrasena	20
12	Balancing oral exposure with Cyp3A4 inhibition in benzimidazole-based IGF-IR inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·Kurt Zimmermann,Mark D. Wittman,Mark G. Saulnier,Upender Velaparthi,David R. Langley,(unknown),David B. Frennesson,Joan M. Carboni,Aixin Li,Ann Greer,Marco M. Gottardis,Ricardo M. Attar,Zheng Yang,Praveen Balimane,Lorell Discenza,Dolatrai M. Vyas	17
13	Constitutively Active Type I Insulin-Like Growth Factor Receptor Causes Transformation and Xenograft Growth of Immortalized Mammary Epithelial Cells and Is Accompanied by an Epithelial-to-Mesenchymal Transition Mediated by NF-κB and Snail 2007 ·Molecular and Cellular Biology ·Hyun Jung Kim,Beate C. Litzenburger,Xiaojiang Cui,David A. Delgado,Brian C. Grabiner,Xin Lin,Michael T. Lewis,Marco M. Gottardis,Tai W. Wong,Ricardo M. Attar,Joan M. Carboni,Adrian V. Lee	196
14	Novel 1H-(benzimidazol-2-yl)-1H-pyridin-2-one inhibitors of insulin-like growth factor I (IGF-1R) kinase 2006 ·Bioorganic & Medicinal Chemistry Letters ·Mark D. Wittman,Balu Balasubramanian,(unknown),Upender Velaparthi,(unknown),(unknown),Joan M. Carboni,Aixin Li,Ann Greer,Ricardo M. Attar,Marco M. Gottardis,ChiehYing Y. Chang,Bruce L. Jacobson,(unknown),Steven Hansel,Mary Zoeckler,Dolatrai M. Vyas	19
15	BMS-554417, an inhibitor of the insulin-like growth factor I receptor and insulin receptor, inhibits proliferation and induces mitochondrial pathway-mediated apoptosis in cancer cell lines 2005 ·Cancer Research ·Paul Haluska,Joan M. Carboni,David A. Loegering,Francis Y. Lee,Mark G. Saulnier,David B. Frennesson,Ricardo M. Attar,Kimberly R. Kalli,Cheryl A. Conover,Sumithra J. Mandrekar,Scott H. Kaufmann,Marco M. Gottardis,Charles Erlichman	2
16	Identification of novel functional inhibitors of 17β-hydroxysteroid dehydrogenase type III (17β-HSD3) 2005 ·The Prostate ·Thomas Spires,Brian E. Fink,Ellen K. Kick,Dan You,Cheryl A. Rizzo,Ivone M. Takenaka,R. Michael Lawrence,Zheming Ruan,Mark Salvati,Gregory D. Vite,Roberto Weinmann,Ricardo M. Attar,Marco M. Gottardis,Matthew V. Lorenzi	22
17	The synthesis and evaluation of [2.2.1]-bicycloazahydantoins as androgen receptor antagonists 2004 ·Bioorganic & Medicinal Chemistry Letters ·Aaron Balog,Mark Salvati,Weifang Shan,Arvind Mathur,Leslie Leith,Donna Wei,Ricardo M. Attar,Jieping Geng,Cheryl A. Rizzo,Chihuei Wang,Stanley R. Krystek,John S. Tokarski,John T. Hunt,Marco M. Gottardis,Roberto Weinmann	25
18	Expression of Constitutively Active IκBβ in T Cells of Transgenic Mice: Persistent NF-κB Activity Is Required for T-Cell Immune Responses 1998 ·Molecular and Cellular Biology ·Ricardo M. Attar,Heather Macdonald-Bravo,Carmen Raventós-Suárez,Stephen K. Durham,Rodrigo Bravo	48
19	A Conditionally Expressed Third Partner Stabilizes or Prevents the Formation of a Transcriptional Activator in a Three-hybrid System 1997 ·Journal of Biological Chemistry ·Franck Tirode,Claudia Malaguti,Francisco Romero,Ricardo M. Attar,Jacques Camonis,Jean‐Marc Egly	92
20	A cycloheximide-inducible gene ofNeurospora crassabelongs to the cytochrome P-450 superfamily 1989 ·Nucleic Acids Research ·Ricardo M. Attar,Erich Grotewold,Guillermo E. Taccioli,(unknown),Héctor N. Torres,(unknown)	14

About Ricardo M. Attar

Ricardo M. Attar is a scholar working on Endocrinology, Diabetes and Metabolism, Hematology and Radiology, Nuclear Medicine and Imaging, having authored 72 papers that have together received 3.2k indexed citations. Recurring topics across this work include Growth Hormone and Insulin-like Growth Factors (17 papers), Monoclonal and Polyclonal Antibodies Research (17 papers) and Hormonal and reproductive studies (11 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (864 citations), Cancer Research (652 citations) and Oncology (877 citations). Ricardo M. Attar has collaborated with scholars based in United States, Germany and Belgium. Frequent co-authors include Marco M. Gottardis, Joan M. Carboni, Chris H. Takimoto, Mark Salvati, Roberto Weinmann, Michael Gilman, Stanley R. Krystek, John S. Sack, Chihuei Wang and Kevin Kish. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact